Esperion Therapeutics, Inc. (ESPR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 459.46M | 167.85M | 360.46M | 342.6M | 318.78M | 338M | 307.56M | 345.11M | 365.61M | 201.06M | 218.23M | 232.13M |
| Cash & Short-Term Investments | 156.16M | 167.85M | 92.45M | 86.06M | 114.63M | 144.76M | 144.72M | 189.3M | 226.61M | 82.25M | 114.83M | 138.47M |
| Cash Only | 156.16M | 167.85M | 92.45M | 86.06M | 114.63M | 144.76M | 144.72M | 189.3M | 226.61M | 82.25M | 114.83M | 138.47M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 132.35M | 140.19M | 118.98M | 107.75M | 81.29M | 80.14M | 67.82M | 60.36M | 54.61M | 48.49M | 42.62M | 40.8M |
| Days Sales Outstanding | 153.11 | 70.78 | 119.45 | 104.4 | 111.77 | 98.48 | 114.2 | 70.85 | 34.06 | 129.97 | 112.97 | 136.25 |
| Inventory | 104.21M | 105.12M | 141.84M | 114.47M | 99.32M | 94.49M | 80.1M | 84.47M | 73.09M | 65.62M | 51.44M | 45.68M |
| Days Inventory Outstanding | 272.47 | 407.85 | 212.74 | 340.8 | 276.54 | 313.34 | 437.94 | 459.3 | 626.47 | 470.19 | 333.94 | 570.11 |
| Other Current Assets | 66.74M | -245.31M | 0 | 0 | 4.82M | 18.02M | 14.91M | 0 | 11.29M | 0 | 6.29M | 4.32M |
| Total Non-Current Assets | 3.07M | 298.03M | 3.56M | 4.49M | 5.25M | 5.82M | 6.56M | 7.21M | 7.45M | 4.73M | 3.08M | 2.5M |
| Property, Plant & Equipment | 3.01M | 3.26M | 3.5M | 4.43M | 5.2M | 5.77M | 6.5M | 7.16M | 7.4M | 4.67M | 3.02M | 2.44M |
| Fixed Asset Turnover | 25.54x | 49.84x | 22.01x | 17.11x | 11.86x | 11.27x | 7.56x | 10.15x | 22.82x | 8.38x | 12.43x | 14.31x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | -123.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.5M |
| Total Assets | 462.53M | 465.89M | 364.02M | 347.08M | 324.03M | 343.82M | 314.11M | 352.32M | 373.06M | 205.8M | 221.31M | 234.63M |
| Asset Turnover | 0.17x | 0.41x | 0.25x | 0.25x | 0.19x | 0.21x | 0.15x | 0.20x | 0.48x | 0.15x | 0.15x | 0.11x |
| Asset Growth % | 42.74% | 35.5% | 15.89% | -1.49% | -13.14% | 67.07% | 41.94% | 50.16% | 48.15% | -17% | -29.26% | -22.82% |
| Total Current Liabilities | 300.36M | 300.81M | 359.03M | 298.8M | 270.97M | 246.23M | 165.87M | 175.34M | 164.51M | 156.22M | 137.71M | 107.17M |
| Accounts Payable | 68.41M | 65.07M | 77.51M | 74.7M | 71.99M | 51.65M | 34.86M | 47.67M | 28.43M | 31.72M | 26.21M | 24.56M |
| Days Payables Outstanding | 173.73 | 235.47 | 126.34 | 233.85 | 176.42 | 155.27 | 219.63 | 221.84 | 271.65 | 232.7 | 174.59 | 279.08 |
| Short-Term Debt | 1.7M | 89.7M | 149.69M | 121.08M | 54.67M | 54.58M | 0 | 0 | 43.49M | 34.83M | 37.01M | 22.78M |
| Deferred Revenue (Current) | 43.53M | 0 | 0 | 0 | 4.54M | 8.52M | 15.08M | 20.67M | 29.35M | 25.4M | 19.72M | 15.63M |
| Other Current Liabilities | 186.72M | 146.04M | 109.19M | 83.61M | 63.66M | 60.33M | 49.53M | 40.23M | 54.74M | 49.24M | 45.59M | 36.52M |
| Current Ratio | 1.53x | 0.56x | 1.00x | 1.15x | 1.18x | 1.37x | 1.85x | 1.97x | 2.22x | 1.29x | 1.58x | 2.17x |
| Quick Ratio | 1.18x | 0.21x | 0.61x | 0.76x | 0.81x | 0.99x | 1.37x | 1.49x | 1.78x | 0.87x | 1.21x | 1.74x |
| Cash Conversion Cycle | 251.84 | 243.16 | 205.85 | 211.35 | 211.89 | 256.56 | 332.51 | 308.31 | 388.88 | 367.46 | 272.32 | 427.28 |
| Total Non-Current Liabilities | 470.1M | 467.04M | 456.35M | 481.8M | 479.27M | 486.31M | 518.45M | 521.2M | 502.85M | 504.57M | 493.6M | 499.43M |
| Long-Term Debt | 250.93M | 457.65M | 448.14M | 473.05M | 238.32M | 237.72M | 262.92M | 262.48M | 498.43M | 501.55M | 261.17M | 260.74M |
| Capital Lease Obligations | 861K | 653K | 767K | 1.31M | 1.97M | 2.57M | 3.3M | 3.98M | 4.42M | 3.02M | 2.05M | 1.7M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 219.17M | 8.74M | 7.44M | 7.44M | 238.98M | 246.02M | 252.23M | 254.75M | 0 | 0 | 230.39M | 236.99M |
| Total Liabilities | 770.46M | 767.85M | 815.38M | 780.59M | 750.24M | 732.54M | 684.32M | 696.54M | 667.36M | 660.79M | 631.31M | 606.6M |
| Total Debt | 252.63M | 548M | 600.99M | 598.18M | 297.78M | 297.6M | 268.96M | 269.13M | 548.87M | 540.95M | 301.14M | 285.91M |
| Net Debt | 96.47M | 380.15M | 508.54M | 512.12M | 183.15M | 152.84M | 124.25M | 79.83M | 322.26M | 458.7M | 186.31M | 147.44M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | 6.43x | - | 83.99x | - | - | - | 103.95x | 7.59x | - | - | - |
| Net Debt / EBITDA | - | 4.46x | - | 71.91x | - | - | - | 30.83x | 4.46x | - | - | - |
| Interest Coverage | -0.33x | 3.77x | -0.42x | 0.38x | -1.08x | -0.30x | -0.96x | -3.51x | 5.35x | -2.74x | -1.75x | -2.44x |
| Total Equity | -307.93M | -301.96M | -451.36M | -433.51M | -426.21M | -388.72M | -370.21M | -344.22M | -294.3M | -454.99M | -410M | -371.98M |
| Equity Growth % | 27.75% | 22.32% | -21.92% | -25.94% | -44.82% | 14.57% | 9.71% | 7.46% | 10.73% | -40.53% | -39.41% | -27.52% |
| Book Value per Share | -1.23 | -1.06 | -2.28 | -2.20 | -2.17 | -1.99 | -1.90 | -1.82 | -1.55 | -4.05 | -3.67 | -3.41 |
| Total Shareholders' Equity | -307.93M | -301.96M | -451.36M | -433.51M | -426.21M | -388.72M | -370.21M | -344.22M | -294.3M | -454.99M | -410M | -371.98M |
| Common Stock | 257K | 245K | 205K | 200K | 197K | 196K | 195K | 195K | 188K | 118K | 112K | 101K |
| Retained Earnings | -1.65B | -1.62B | -1.69B | -1.65B | -1.64B | -1.6B | -1.58B | -1.55B | -1.49B | -1.55B | -1.49B | -1.45B |
| Treasury Stock | -55M | -55M | -55M | -55M | -55M | -55M | -55M | -55M | -55M | -55M | -55M | -55M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |